NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
ShanXi C&Y Pharmaceutical Group Co. Ltd (SHE: 300254)
300254 Technical Analysis
5
As on 29th Jul 2025 300254 STOCK Price closed @ 12.29 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 8.71 & Strong Buy for SHORT-TERM with Stoploss of 8.47 we also expect STOCK to react on Following IMPORTANT LEVELS. |
300254STOCK Price
Open | 11.79 | Change | Price | % |
High | 12.55 | 1 Day | 0.39 | 3.28 |
Low | 11.55 | 1 Week | 0.94 | 8.28 |
Close | 12.29 | 1 Month | 1.47 | 13.59 |
Volume | 59188095 | 1 Year | 3.84 | 45.44 |
52 Week High 11.86 | 52 Week Low 5.21 |
SHE China Most Active Stocks
002570 | 6.72 | 3.54% |
000617 | 9.77 | 4.16% |
300059 | 24.18 | 0.25% |
000981 | 2.08 | 0.97% |
002607 | 3.00 | -1.32% |
000725 | 4.11 | 0.24% |
002097 | 13.32 | 9.99% |
300267 | 4.26 | -1.84% |
002437 | 3.53 | 3.82% |
000558 | 5.99 | 4.90% |
SHE China Top Gainers Stocks
SHE China Top Losers Stocks
300254 Daily Charts |
300254 Intraday Charts |
Whats New @ Bazaartrend |
300254 Free Analysis |
|
300254 Important Levels Intraday
RESISTANCE | 14.22 |
RESISTANCE | 13.60 |
RESISTANCE | 13.22 |
RESISTANCE | 12.84 |
SUPPORT | 11.75 |
SUPPORT | 11.36 |
SUPPORT | 10.98 |
SUPPORT | 10.36 |
300254 Forecast July 2025
4th UP Forecast | 20.11 |
3rd UP Forecast | 17.6 |
2nd UP Forecast | 16.05 |
1st UP Forecast | 14.5 |
1st DOWN Forecast | 10.08 |
2nd DOWN Forecast | 8.53 |
3rd DOWN Forecast | 6.98 |
4th DOWN Forecast | 4.47 |
300254 Weekly Forecast
4th UP Forecast | 15.53 |
3rd UP Forecast | 14.49 |
2nd UP Forecast | 13.85 |
1st UP Forecast | 13.21 |
1st DOWN Forecast | 11.37 |
2nd DOWN Forecast | 10.73 |
3rd DOWN Forecast | 10.09 |
4th DOWN Forecast | 9.05 |
300254 Forecast2025
4th UP Forecast | 26.88 |
3rd UP Forecast | 22.2 |
2nd UP Forecast | 19.31 |
1st UP Forecast | 16.42 |
1st DOWN Forecast | 8.16 |
2nd DOWN Forecast | 5.27 |
3rd DOWN Forecast | 2.38 |
4th DOWN Forecast | -2.3 |
ShanXi C&Y Pharmaceutical Group Co. Ltd ( SHE China Symbol : 300254 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
300254 Other Details
Segment | EQ | |
Market Capital | 1290315904.00 | |
Sector | Healthcare | |
Industry | Drug Manufacturers-Specialty & Generic | |
Offical website | > echo $website ; ?> |
300254 Address
![]() |
300254 Latest News
300254 Business Profile
ShanXi C&Y Pharmaceutical Group Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China, the United States, Hong Kong, and internationally. It offers products for pregnant women and babies; urinary system products; anti-infection products; traditional Chinese medicines; and dermatology products, as well as tea bags. The company was formerly known as Shanxi C&Y Pharmaceutical Co., Ltd. and changed its name to Shanxi C&Y Pharmaceutical Group Co., Ltd. in September 2014. Shanxi C&Y Pharmaceutical Group Co., LTD. was founded in 2005 and is headquartered in Shanghai, China. Address: Tower A, Shanghai, China, 200051
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service